FT : Deadly storm in Chile disrupts copper mines and raises AI supply concerns M

Deadly storm in Chile disrupts copper mines and raises AI supply concerns
Metals boom is reliant on high-altitude, declining mines that are exposed to increasing weather volatility

A deadly storm in Chile threatens copper production and has added to concerns over the industry’s ability to supply the metal crucial to the AI boom.

Canadian base metals group Lundin Mining suspended operations at its Caserones copper–molybdenum operation in Chile’s Atacama region last week, where heavy snowfall had disrupted power supplies, while copper miner Antofagasta paused mining and processing for several days at its Minera Los Pelambres site.

The extreme weather caused flash flooding, as well as heavy snow at higher altitudes where some major copper mines are located. The storm has killed at least 13 people, according to officials.

Snow also affected some operations at state-run copper miner Codelco, where operations at major mines including El Teniente were temporarily halted. Executives at majors including Anglo American and BHP are also closely monitoring the situation and in touch with Chilean authorities. 

Copper is essential for the build-out of electricity grids, renewable energy and the data centres that will power AI. But experts are forecasting a widening shortage of the red metal in the decades to come, with supply shocks likely to become more common as climate change accelerates and fuels extreme weather events.

With copper stocks in the global network of London Metal Exchange warehouses already declining, “added supply risks like Chile are only upping the ante to copper price volatility”, said StoneX analyst Natalie Scott-Gray.

More broadly, mining investors “are increasingly trying to understand how physical [climate] risk translates into production disruption, cash flow, insurance costs and asset valuation”, said Giuseppe Amitrano, founder of risk analysis group WieldMore Investment Management. In a mining nation such as Chile, “even temporary disruption can matter for commodity markets”, he said.

Although miners typically bake some weather-related disruption into their forecasts, doing so accurately is likely to become more challenging as weather patterns change.

The disruption in Chile — where a state of emergency has been declared in certain regions — comes days after miners including BHP warned of declining copper production thanks in part to ageing mines that over time contain less of the red metal.

Accidents and interruptions at major mines last year helped propel the copper price to a series of record highs. Prices have continued to rise in recent weeks on fears that the US could impose new copper import tariffs and as Chinese buying has picked up.

Many mines are in areas at risk from extreme weather events, the frequency of which is increasing thanks to climate change. That could mean more operations being halted, with concerns also rising about the demand for water by the sector in countries that are at growing risk of drought.


“There is a risk that as more mines are built in countries that are already water-stressed, that increases the pressure on the system,” said Benchmark analyst Albert Mackenzie.

Older mines, where the concentration of metal in the ground may be lower, required more water to produce copper, he added. “The lower the ore grade is, the more water they use. So the older the deposit, the more water they’ll need.”


Industry body ICMM warned this week that a third of 12,000 metals and mining facilities globally were in areas experiencing “high competition for water” and at high risk of drought, and flagged Chile as a country of particular concern.

An analysis this month by Jefferies found that global copper production had fallen nearly 10 per cent in the latest quarter compared with the same period last year, based on updates from miners that represent about a fifth of global mined copper supply. That increased the risk of “sizeable deficits” in the market in the next 12 months, they said. 

The International Energy Agency also warned last week of “mounting difficulties” in miners being able to sustain copper production at current levels in countries including Chile and Peru.

FT : British unicorn Humanoid points to way forward for European tech London-bas

British unicorn Humanoid points to way forward for European tech
London-based company shows that while the continent is industrialising, it still has manufacturing clout

Victoire! Tech laggard Europe scored a pair of wins last week. Britain’s Humanoid became Europe’s first pure-play robotics “unicorn”, achieving a post-money valuation of just under $1.4bn. And Mistral of France snagged chipmaker Samsung as a participant in its latest funding round, putting an expected €20bn sticker on the continent’s AI champion.

Granted, by global standards, Humanoid is a mere homunculus. In China, Unitree Robotics, expected to achieve a roughly $6bn valuation at its upcoming Shanghai listing, is one of a hundred Chinese companies focused on “embodied AI”. In the US, FigureAI commands a $39bn valuation; tech tsar Elon Musk says his Optimus humanoids will be “the biggest product ever created”.

But the London-based company offers a compelling roadmap for European tech, showing that while the continent is deindustrialising, it still has manufacturing clout. For example, Humanoid is tapping Bosch as a contract manufacturer, capitalising on the German group’s expertise in high-power, complex parts. That is doubly useful in an industry heavily reliant on safety certification.

Similar skill sets are available in the industry’s fledgling supply chain. Germany’s Schaeffler will supply the powerful high-precision actuators, the “muscles” which make up half of humanoids’ material costs and are vulnerable to bottlenecks. As humanoids are given more demanding tasks, called upon to lift heavier loads and keep going longer on fewer charges, actuators will need to keep pace.

These German partners are also investors and future customers. While reminiscent of the old Japanese keiretsu structure of interlinked commercial relationships and cross-shareholdings, this also borrows from the playbook of AI titans like OpenAI and Nvidia who invest in their buyers. In theory, that should pay off for both sides: keeping factories ticking and establishing supply chain resilience for Humanoid. The company aims to produce 150,000 units in 2030 and to generate revenue in the billions of dollars in the year prior.

Mistral, while the bigger company of the two, is on less convincing ground. The $6bn of funds it has raised, including in the current round, is much the same as Google burned through in a mere three months. Its business model of embedding engineers in clients’ businesses to deploy AI makes it a rather different beast from blockbuster model makers like Anthropic or China’s Moonshot AI.

Mistral’s key selling point is that Europe wants tech sovereignty and it has virtually no competition of similar size on home turf. That’s a way to get customers, particularly from the public sector, but hardly a recipe for global greatness. Humanoid, by contrast, is playing to Europe’s existing strengths — with a nod to Silicon Valley’s penchant for mutual industrial back-scratching. In this case, the stuff of science fiction looks like the more viable bet.

WSJ : Van Rams Into Crowd at Berlin Pride Parade, Killing One More than a dozen

Van Rams Into Crowd at Berlin Pride Parade, Killing One
More than a dozen people were injured; police say suspect has ties to Islamic extremist groups

  • A van rammed into a crowd during an LGBTQ pride parade in Berlin, killing one person and injuring more than a dozen others.
  • The parade was canceled, and authorities said they were searching for the suspect, who was identified as a man with ties to Islamic extremist groups.
  • Berlin Mayor Kai Wegner called the incident a brutal attack on the city.

One person died and more than a dozen others were injured after a van rammed into a crowd during an LGBTQ pride parade in Berlin on Saturday.

Police identified the suspect as a man who has ties to Islamic extremist groups and is known to authorities in the German capital. Police didn’t release his name and said they were still searching for him.

Berlin police said the man drove a white van into Tiergarten park shortly before 10 p.m. and then crashed into a crowd. The parade was canceled, and attendees were told to go home.

About one million people attend the event, called the Christopher Street Day parade, to commemorate the 1969 gay uprising against police brutality at Stonewall Inn on New York City’s Christopher Street. The parade winds through Berlin and ends with performances in front of Brandenburg Gate, near the park where the incident occurred.

Police said that 16 people were hurt, several with life-threatening injuries, and that a motive was still being investigated.

Berlin Mayor Kai Wegner called the incident a brutal attack on the city and said his thoughts were with the victims.

The Information : Nvidia Forms $500 Billion AI ‘Partnership’ With Memory Chip Gi

Nvidia Forms $500 Billion AI ‘Partnership’ With Memory Chip Giant SK
The AI giant is continuing to use its balance sheet to help its biggest customers and partners buy and manufacture its AI servers.

Nvidia on Friday announced a $500 billion partnership with the conglomerate that owns SK Hynix, whose high-bandwidth memory chips are critical to Nvidia’s AI servers. The partnership aims to help Nvidia access more memory chips and fill more data centers with its servers.

Nvidia’s representatives didn’t elaborate on which firms would spend such a large amount or precisely what it would be for. Nvidia and the SK Hynix parent company said they would build two gigawatts of AI cloud capacity together, which could cost around $100 billion, based on today’s prices for data centers that consume such power. Their engineers also plan to work more closely together to develop new high-bandwidth memory products.

An Nvidia executive said the company’s biggest priority is to get its AI servers online as fast as possible, so it’s helping more customers find land, power, memory and raw materials to make AI data centers happen quickly.

“ What’s limiting the access to compute capacity is the fact that it’s very hard to find powered data centers, powered land,” said Raj Mirpuri, Nvidia’s vice president of global AI clouds and infrastructure, in a briefing with reporters. For instance, he said Nvidia helped Naver, the South Korean search firm, secure access to land and power to expand an AI data center from 55 megawatts to 200 MW by 2028. (Such a facility is relatively small compared to AI facilities underway in the U.S.)

Nvidia also plans to invest $1 billion in Naver and asset manager Brookfield has committed to fund the project with $9 billion. Naver is set to pay for the rest. The new data center is expected to start with Nvidia’s Grace Blackwell server racks and later add next-generation Vera Rubin racks.

Nvidia is increasingly using its balance sheet to help its customers afford more AI chips and help its cloud provider partners get financing to build new facilities for the chips.

The Information : SpaceX completes first Starship test flight since IPO The test

SpaceX completes first Starship test flight since IPO
The test flight marked several key milestones for SpaceX, including deploying 20 of its next generation Starlink satellites into orbit for the first time before they were intentionally deorbited.

SpaceX completed its 13th test flight of its Starship rocket on Friday night after aborting a test launch last week, the first completed launch since the company went public last month.

The test flight marked several key milestones for SpaceX, including deploying 20 of its next generation Starlink satellites into orbit for the first time before they were intentionally deorbited. The satellites are designed to be larger and more powerful than previous generations and the test allowed the company to see how the satellites would perform in flight for the first time.

SpaceX said in a statement that the Super Heavy booster separated from Starship as planned but made a “hard splashdown” in the Gulf after only some of its engines reignited during the landing burn. SpaceX CEO Elon Musk said that the rocket’s next test might be even more advanced. “Unless we discover problems after mission data review, SpaceX will attempt to catch the ship with the tower on next flight,” he wrote on X.

Starship is central to SpaceX’s ambitions to dramatically expand its Starlink network and support future missions with NASA. Shares of the rocket company have been trending lower in recent weeks and is now well below the initial public offering price of $135 last week.

(ZeroHedge) China Is Now Viewed More Favorably Than America Tyler Durden's Photo

China Is Now Viewed More Favorably Than America

Public opinion toward the world’s two leading powers has undergone a notable shift. Pew Research Center’s Spring 2026 Global Attitudes Survey reveals significant differences in how countries perceive China and the United States.
The visualization below, created by Visual Capitalist's Iswardi Ishak using Pew Research Center data, compares favorability toward both countries across 36 nations, showing where each holds the strongest public support and where opinions remain closely divided.
How the World Views the U.S. and China
The chart below plots favorable opinions of China and the U.S. using Pew Research Center’s Spring 2026 Global Attitudes Survey.
Regional differences are pronounced. Many countries in Africa, Southeast Asia, and parts of Latin America express more favorable views of China. The U.S. leads in nine countries: Brazil, Ghana, Hungary, India, Israel, Japan, the Philippines, Poland, and South Korea.
The Development Divide
The scatterplot reveals several broad clusters. Wealthier Western democracies generally remain skeptical of both countries, with Germany, France, Sweden, Australia, and the Netherlands posting relatively low favorability ratings for each.
Much of the developing world falls into the opposite quadrant, where China receives majority support while views of the U.S. lag behind. Pakistan stands out with a 90% favorable opinion of China versus 15% for the United States. Large gaps also appear in Malaysia (75% vs. 19%) and Indonesia (72% vs. 29%).
Several African countries, including Ghana, Kenya, and Nigeria, express positive views of both powers. This suggests many respondents see value in maintaining relationships with each country rather than viewing them as mutually exclusive.
Why China’s Image Has Improved
China’s improving standing reflects both rising favorability toward Beijing and declining perceptions of the United States. Recent reporting indicates that this reversal has been especially pronounced among several longstanding U.S. partners, including Canada and countries across Europe.
Public opinion rarely hinges on a single issue. Analysts point to expanding Chinese trade and diplomatic engagement, alongside changing perceptions of U.S. foreign policy and reliability. As countries deepen economic ties with Beijing, trade has become an increasingly important factor in international relationships.
Coverage from the BBC and analysis from the Council on Foreign Relations also suggest that many countries are pursuing pragmatic relationships with both powers, balancing security partnerships with growing economic ties to China.
Soft Power Remains a Global Competition
Although China receives stronger favorability ratings across most countries surveyed, the results do not necessarily translate directly into geopolitical alignment.
Instead, the survey points to an increasingly multipolar world in which economic influence, trade, diplomacy, and public perception all contribute to global power. As China expands its international presence and the U.S. works to maintain longstanding alliances, competition between the two superpowers is increasingly measured not only in economic and military terms, but also through global public opinion.

Daily Beast : GLP-1 Jabs Linked to Rare Side Effect That’s Worse Than ‘Ozempic F

GLP-1 Jabs Linked to Rare Side Effect That’s Worse Than ‘Ozempic Face’
This front-and-center side effect might hit even harder than cramping, pain, and a bit of loose skin.

Blockbuster weight-loss drugs are being linked to a rare but upsetting side effect that’s showing up in the shower drain.

As the popularity of GLP-1 medications for type 2 diabetes and obesity continues to skyrocket, patients and doctors report a growing list of side effects. Some are common, such as vomiting, bloating, cramping, and loose skin, colloquially known as “Ozempic face.” Others are rare, including “Ozempic feet,” mood changes, and even scurvy.

Still, even with all the potential side effects, more people than ever are being prescribed semaglutide and tirzepatide. But new research on a rare yet devastating side effect may deter some prospective GLP-1 seekers: hair loss.

A study by researchers at the University of Pennsylvania found that people taking GLP-1 medications such as Ozempic, Wegovy, and Mounjaro faced a higher risk of developing alopecia than patients taking two other classes of diabetes drugs.

The study, published Wednesday in The BMJ, a globally respected peer-reviewed British medical journal, followed patients for an average of 2.7 years and found that the increased risk was concentrated in non-scarring alopecia—a type of hair loss that does not permanently destroy the follicles.

After at least two years of treatment, GLP-1 users had a 37 percent higher chance of developing alopecia than patients taking SGLT-2 drugs and 68 percent higher odds than those taking DPP-4 drugs, both of which are also used to treat type 2 diabetes.

The actual risk, however, remained low.

Researchers recorded approximately three to nine cases of alopecia for every 1,000 patients each year. That translates to roughly seven GLP-1 users developing hair loss, compared with five SGLT-2 users and four DPP-4 users annually.

The findings may sound familiar to those who follow news about GLP-1s.

Comedian and influencer Claudia Oshry revealed in 2024 that her hair began “shedding” after she lost 70 pounds while taking Ozempic.

“It didn’t thin, but it started SHEDDING—which is literally worse,” the 31-year-old said during an Instagram Q&A. She added that it took six to nine months for her hair to “get back to normal.”

Buying Beverly Hills star Sophia Umansky, the 26-year-old daughter of The Real Housewives of Beverly Hills star Kyle Richards, also documented “dramatic” hair loss after taking Mounjaro.

In an April 2025 TikTok, Umansky showed viewers the clumps of hair she had collected in her bathroom and joked that she would be “bald” within a week.

Umansky did not blame Mounjaro itself. She suspected that rapid weight loss and not consuming enough protein and vitamins had triggered the shedding.

Scientists are still trying to determine why some GLP-1 users lose hair.

According to the study’s researchers, rapid weight loss can disrupt the hair’s normal growth cycle and trigger telogen effluvium, a common and generally temporary form of shedding.

Changes in eating habits may also leave patients deficient in nutrients such as iron and zinc, which can further interfere with hair growth, according to the National Library of Medicine.

The medical records did not show how severe the patients’ hair loss was, how long it lasted, or whether their hair eventually grew back.

'Buying Beverly Hills' Star Reveals Rapid Hair Loss After GLP-1 Use

Other research suggests that weight loss alone may not fully explain the shedding.

A study published in the Journal of the American Academy of Dermatology compared more than 1 million GLP-1 users with patients taking metformin, a common diabetes drug that is not associated with the same dramatic weight loss.

The researchers found increased risk of several forms of alopecia among those taking GLP-1 medications.

Researchers emphasized that hair loss rarely causes physical harm but can still take an emotional toll, the degree of which is highly personal.

“Hair loss is a patient-valued outcome,” lead researcher Yong Chen wrote, adding that it can affect “self-esteem, quality of life, and adherence to treatment.”

For many, the benefits vastly outweigh the drawbacks, but researchers said the findings should help patients understand the potential trade-offs before starting—or deciding whether to continue—the highly popular medication.

TechCrunch : SpaceX launches new V3 Starlink satellites but suffers another boos

SpaceX launches new V3 Starlink satellites but suffers another booster failure

SpaceX successfully deployed the first third-generation Starlink satellites on Friday using an upgraded version of its prototype Starship — the 13th test flight of its mega-rocket to date. But the company suffered another failure with its Super Heavy booster during a planned simulated landing in the Gulf of Mexico.

It’s the second time the company has had an issue with the Super Heavy booster on this V3 version of Starship. In May, on the first Starship V3 flight, SpaceX encountered a failure of the Starship’s Super Heavy booster as it separated from the upper stage of the rocket. SpaceX was able to perform a simulated landing of the upper stage of Starship during Friday’s launch after it deployed the Starlink satellites.

The launch came a little more than a week after SpaceX tried to conduct the 13th Starship launch. That attempt had to abort immediately after ignition due to a number of rocket engine failures. SpaceX said it replaced six engines ahead of Friday’s flight to fix the problem.

During Friday’s launch, the booster made it farther into its planned flight but wasn’t able to properly fire up all of the engines required for its simulated landing burn. The booster exploded after a faster-than-expected impact with the water.

This was the first launch of Starship since SpaceX went public in June in the largest IPO in history. In a test of SpaceX’s “fly, fail, fix” approach to Starship development, the company saw its stock decline last week in the day following the launch abort. The dip is part of a larger downward trend since the IPO that has seen the company’s stock drop from a peak of more than $200 per share to $115 at the close of trading on Friday. In after-hours trading, SpaceX shares fell another 2% following the booster failure, before paring some of those losses.

SpaceX had better luck with the Starship V3 upper stage during Friday’s launch. The upper stage lost a rocket engine during the first V3 launch in May. That didn’t happen this time around, as Starship encountered no issues on its way to deploying the new Starlinks. The Ship, as the company calls it, was able to survive the harsh forces of atmospheric reentry and perform a simulated landing in the Indian Ocean roughly one hour after liftoff.

Unlike previous Starship missions, the Ship didn’t explode when it tipped over into the water. The Ship instead floated around in the water, giving SpaceX a chance to use a drone to closely examine the heat shield tiles on its belly.

The new Starlink satellites burned up in the atmosphere roughly 20 minutes after deployment, as Starship still isn’t capable of reaching Earth orbit. SpaceX was able to communicate with all of them while they were in space, marking a step forward for that program, which is the only profitable part of the company’s business.

The ability to deploy the more capable V3 Starlink satellites improves the economics of the company’s capital-hungry space internet network. SpaceX has said launching 60 of the new satellites on Starship is a “potential twenty-fold increase” in downlink capacity deployed versus those flown by a single Falcon 9.

However, it’s not clear if SpaceX can realize those gains if Starship expends the Super Heavy booster rather than reusing it. SpaceX’s S-1 said that without a fully-reusable Starship, progress on Starlink “would be at a slower pace and higher cost.”

The New Yorker : Should We Do More to Fight Lookism? Discrimination against the

Should We Do More to Fight Lookism?
Discrimination against the unattractive is widespread—and widely tolerated.

n 2007, Miranda Fricker, a British philosopher, published a book called “Epistemic Injustice: Power and the Ethics of Knowing.” It became a smash hit, philosophically speaking, because it diagnosed a problem that had been hard to put into words. Imagine that you witness a crime, Fricker wrote, but find that the police won’t credit your testimony because of the color of your skin. Or suppose you’re being tormented by someone in power, but lack the ability to explain to others—or even to yourself—exactly how you’re being wronged. (You might be like the women in “Mad Men,” who were being sexually harassed by their bosses but lacked the term “sexual harassment.”) These two kinds of injury seem different but are actually related, Fricker argued, because they both have to do with knowledge. In the first case, you know something, but no one will listen to you; in the second, you have trouble fully knowing what’s going on in your life. In either case, you’re suffering from an unfairness of knowledge that limits what you’re able to communicate, what others are willing to hear from you, or what you can understand about yourself and your circumstances.

In the years since the appearance of Fricker’s book, the effort to overcome bias and discrimination has acquired a new flavor. In this latest phase, many harms that were once difficult to describe have been given names, so that they can be better identified and confronted. (We now talk about mansplaining, microaggressions, and gaslighting.) Populations that might not otherwise have seen what they have in common—neurodivergent people, or patients with contested diagnoses—have formed identities and found cause for solidarity. It can be life-changing to have a name for what harms you; society can shift when new groups assert themselves. And yet the pursuit of epistemic justice also risks what the psychologist Nick Haslam has called concept creep—“the progressive expansion of concepts of harm.” The new terms or categories that some find liberating might not reflect an underlying reality. (Not all patients with contested diagnoses face the same struggle.) A new identity can create burdens that aren’t easily shrugged off.

“I have never, until now, confessed to anyone that I felt I was ugly,” the journalist Stephanie Fairyington writes in her new book, “Ugly: A Letter to My Daughter.” Since childhood, she’s felt unattractive; she’s also found it “hard to say the words I am ugly or even I am seen as ugly.” When she’s succeeded in giving voice to such ideas, perhaps using softened language (“My looks aren’t my strong suit”), well-meaning people are quick to disagree, telling her that she looks good. But she’s certain that this isn’t true, and that her appearance has shaped her life. She recalls a moment from her childhood, on “a sunny day in 1986,” when the mother of a friend, parked in a minivan, leaned out the window and exclaimed, incredulously, “That’s Chrysí’s daughter?” Fairyington’s mother and brother were notably good-looking. “Where they had full lips, I had thin ones,” she writes. “Where they had aquiline noses, I had a bulbous red one.” Moreover, “it wasn’t just my face that made me unattractive . . . it was also the legibility of my queerness.”

“I have never, until now, confessed to anyone that I felt I was ugly,” the journalist Stephanie Fairyington writes in her new book, “Ugly: A Letter to My Daughter.” Since childhood, she’s felt unattractive; she’s also found it “hard to say the words I am ugly or even I am seen as ugly.” When she’s succeeded in giving voice to such ideas, perhaps using softened language (“My looks aren’t my strong suit”), well-meaning people are quick to disagree, telling her that she looks good. But she’s certain that this isn’t true, and that her appearance has shaped her life. She recalls a moment from her childhood, on “a sunny day in 1986,” when the mother of a friend, parked in a minivan, leaned out the window and exclaimed, incredulously, “That’s Chrysí’s daughter?” Fairyington’s mother and brother were notably good-looking. “Where they had full lips, I had thin ones,” she writes. “Where they had aquiline noses, I had a bulbous red one.” Moreover, “it wasn’t just my face that made me unattractive . . . it was also the legibility of my queerness.”

Fairyington cites the philosopher Thomas J. Spiegel, who, in a paper from 2022, argued that “lookism”—discrimination based on unattractiveness—is not just unfair in itself but also a form of epistemic injustice. Lookism’s existence is beyond dispute: research has shown that pretty people have an easier time making money, finding partners, and even succeeding in court, while unattractive people are judged more harshly, treated more meanly, and seen as lower performing. Yet there is a “taboo” around the subject of ugliness, Spiegel writes, that leads us to hide from ourselves the toll it takes on individuals. Lookism “does not generate the same awareness as gender or race-based discrimination partially for the reason that there is a different kind of discomfort associated with being identified as ugly,” he writes.

“Ugly” is an ugly word. It’s painful to point it at yourself, and cruel to point it at others. It’s also a complicated word, since, as Fairyington shows in her wide-ranging book, beauty and ugliness are not just aesthetic ideas—they have cultural, biological, subjective, intersubjective, political, commercial, and historical dimensions. All this contributes to the fact that there’s no National Association for Unattractive People. No one urges H.R. departments to hold training sessions on overcoming lookism in the workplace; schools don’t teach kids about the costs of lauding beauty and denigrating its opposite. This gap in our defenses against bias may be understandable—but it leaves lookism unnamed and unopposed. What would it take for us to face the problem directly?

The writer Ted Chiang imagines a solution to lookism in the short story “Liking What You See: A Documentary.” In his near-future scenario, it’s become easy and cheap to get your brain modified so that you don’t notice facial beauty. Someone who’s undergone the reversible procedure, which is called calliagnosia—kalos is the Greek word for beauty—“can tell the difference between a pointed chin and a receding one, a straight nose and a crooked one, clear skin and blemished skin,” a neurologist explains. But “he or she simply doesn’t experience any aesthetic reaction to those differences.” The story’s protagonist, a college freshman named Tamera, had the procedure done when she was a child, because her progressive parents were against lookism. Gazing into the mirror, she can’t tell if she’s pretty. It’s only when someone else sees a picture of her with her ex-boyfriend that she learns that she’s out of his league.

At Tamera’s college, an organization called Students for Equality Everywhere, or SEE, wants to amend the school’s code of conduct so that calliagnosia is mandatory. They argue that it makes no sense to fight racism and sexism while tolerating lookism. They also point out that young people are pawns in a technological-arms race. In the story, generative video technology is being used to make models, spokespeople, and politicians unnaturally persuasive, charismatic, and beautiful. An advocate of calliagnosia says that, while it’s reasonable to enjoy looking at ordinary beautiful people, these digital manipulations conjure the equivalent of “pharmaceutical-grade beauty”—“the cocaine of good looks.” Various people in Chiang’s story proffer all sorts of arguments, philosophical, practical, and aesthetic, against blocking the perception of human beauty. But others decide to fight fire with fire, or embrace the technology on philosophical grounds. “The foundations of our culture were laid in classical Greece, where physical beauty and the body were celebrated,” a religion professor at the college explains. “But our culture is also thoroughly permeated by the monotheistic tradition, which devalues the body in favor of the soul.”

It’s interesting to consider how our present-day world compares with Chiang’s fictional one. Like the students in his story, we’re living in an age of technologically accelerated lookism. In our sci-fi reality, those with the means can use GLP-1s to become ultra-slim; they can employ cosmetic surgery to reverse signs of aging, and to redesign their faces and bodies so that they reflect algorithmically adjudicated images of “perfection.” Dating websites reduce people to photographs, even as photo editing gets easier; the video-conferencing apps we use for work offer to enhance our appearances. We are, quite literally, surrounded by “pharmaceutical-grade beauty.” And yet our world, unlike the one in the story, does not offer an equivalent of calliagnosia. Although there are some circumstances in which we can make “blind” decisions—in ninth grade, I auditioned for the school orchestra from behind a curtain—for the most part, our predicament is worse than theirs.


We might, therefore, conclude that we have no choice but to confront lookism head on. What would that effort look like? In her book “The Beauty Bias: The Injustice of Appearance in Life and Law,” from 2010, the legal scholar Deborah L. Rhode proposed that appearance ought to be added to current anti-discrimination laws. Today, there are jurisdictions, across the country, in which discrimination based on height and weight is specifically outlawed; only a handful of statutes use words such as “appearance.” We might imagine a world in which people more regularly sue their employers for appearance-based discrimination. (But would that be a better world?) In the past, it was not unusual to include a photograph of yourself when you submitted a résumé—an obvious vector for lookism—but the hiring process has evolved. Photographs are often prohibited, and anonymized applications and structured interviews have become more commonplace. And yet the consequences of such measures are hard to predict. There is some evidence that they lead to the hiring of candidates who end up performing better at work. But a study conducted by the Australian government, based on “blind” hiring practices in the Australian Public Service, found that they had unpredictable effects on bias, in part because “de-identification may frustrate efforts aimed at promoting diversity.”

In “Beauty Pays: Why Attractive People Are More Successful,” from 2011, the economist Daniel Hamermesh attempts to estimate the “beauty premium”: he suggests that attractive people earn about a hundred and forty thousand dollars more than regular people over a lifetime. (The effect is “not small, it’s not huge,” Hamermesh has said.) In a concluding section, he weighs various options for compensating or protecting those who are denied that premium. One challenge is that attractiveness unfolds along a spectrum, rather than in categories; if the whole bottom third of the spectrum were protected, it would be the largest protected class in society. Even if it existed, would it be a class that people wanted to join?

Moral progress isn’t confined to legislation, of course. It also happens individually and interpersonally; it’s created and promulgated one person at a time, through conversation. In “Ugly,” Fairyington shows how she and her spouse, Sabrina, have tried to give their daughter the tools she’ll need to perceive and resist lookism. In ways both sophisticated and simple—visiting museums, going shopping, listening to Le Tigre—they offer their child a rich understanding of the forces that shape our relationships with our corporeal selves. Their conversations can be hyper-intellectual: “Teasing apart your friend’s ‘fat’ comment, I thought about how the neo-Assyrians preferred heaviness over thinness,” Fairyington writes. But they’re also frank and revelatory; often, they move from questions about bodies or body image into discussions of history, politics, and the broader human experience. As a parent myself, I found the book inspiring.

Around the time he published “Beauty Pays,” Hamermesh did a Q. & A. with readers of the blog “Freakonomics.” “Take advantage of what you’re good at—other things in which you have a comparative advantage,” he told a reader who asked about “how to utterly defeat pretty people.” “Looks are only one of many things that affect success,” he went on. Although Hamermesh was speaking in the language of economics, this isn’t too different from some of what Fairyington puts into practice. An important way to fight lookism is by recognizing human multidimensionality. Like all forms of prejudice, lookism flattens people; we can resist it by being curious, open-minded, and expansive. We can notice that giving in to lookism—a harm we can inflict by degrees, and visit upon ourselves—becomes easier when we use technologies that encourage shallow relationships and assessments.

Does this require us to break the taboo around ugliness—to name it, as Fairyington does? Reading her story, I found myself uncertain. Throughout the book, Fairyington uses the word “ugly” to speak with clarity and force about unfairness. Hearing the term directed at her in middle school was “a new kind of painful,” and it “solidified my ugly self-concept”; at the same time, it “provided a weird kind of relief to know, unequivocally, that my self-understanding was accurate.”

And yet, as Fairyington’s narrative shows, the self-understanding she achieved as a middle schooler wasn’t accurate. Back then, she heard “ugly” as an epithet, simple, brutal, and factual—an objective verdict. But “ugly,” as she uses it in “Ugly,” turns out to be a different kind of word: to use it to describe yourself is to evoke a whole constellation of values, many of them questionable, being brought to bear on a person whose inherent dignity resists them. It’s a word that wishes to undo itself—a word that, if we were truly to vanquish lookism, wouldn’t be needed.

The New Yorker : “No One Knows When It Will End”: A Doctor on the Ebola Emergenc

“No One Knows When It Will End”: A Doctor on the Ebola Emergency
Health-care workers in the Democratic Republic of the Congo are fighting the third-largest outbreak in history—and trying not to get infected themselves.

On May 17th, the director general of the World Health Organization declared the current Ebola outbreak a public-health emergency of international concern in the Democratic Republic of the Congo and in Uganda. More than twenty-four hundred people have tested positive and more than nine hundred and ninety have died, in the third-largest outbreak ever recorded. “It’s like a big fire,” Chikwe Ihekweazu, the executive director of the W.H.O. Health Emergencies Programme, told me. “The center of it is still hot, and it’s also spreading.” Many factors are fanning the flames: the area has been wracked by conflict, global funding cuts have weakened the health system, and an exodus of health-care staff has deprived hospitals of experience from previous outbreaks. The early phases of Ebola can be indistinguishable from those of infections such as malaria and typhoid fever, but the virus eventually causes fluid losses that can lead to shock, multi-organ failure, and a mortality rate that often exceeds fifty per cent. The most profound complication is hemorrhagic fever, in which platelet counts drop and the blood loses its ability to clot normally, leading to bleeding throughout the body.

On July 19th, I spoke with Abdou Sebushishe, a physician and a senior global-health adviser with the International Medical Corps, who hails from Goma, in eastern D.R.C., about what it’s like to care for patients with Ebola right now. Sebushishe previously worked on the Ebola response in Liberia, Sierra Leone, and South Sudan. The D.R.C. has experienced sixteen previous Ebola outbreaks—just last year, Sebushishe responded to one of them in the Kasai province—but this one is different. Some early patients were tested for the wrong strain of Ebola, so infections initially went undetected. “Modelling has suggested that the outbreak might have started in February,” Sebushishe told me. “We missed the critical window of detecting, isolating, and tracking cases early.” A major 2018 outbreak in the D.R.C. took nearly eight months to grow beyond a thousand cases. This time, a thousand people were confirmed positive within the first forty days of the emergency response. Experts continue to worry that the outbreak could spread to neighboring countries. (The risk to the U.S. remains low.)

Bunia General Hospital, where Sebushishe spends much of his time, comprises an aging cluster of buildings and employs about a hundred and fifty health-care workers. Arriving patients wash their hands, have their temperatures taken, and are assessed in a triage area. Anyone with Ebola symptoms is sent to the Ebola Treatment Center (E.T.C.), a semipermanent wood structure surrounded by barbed wire. “Non-Ebola patients cannot cross to the treatment center,” Sebushishe told me. “That could cause them a problem.” His day usually begins at 5 or 5:30 A.M. He showers, drinks coffee, and sends e-mails to help coördinate teams across the D.R.C. Then he goes to the hospital and prepares to treat patients. His account has been edited for length and clarity.

“At 8 A.M. every day, the team that was on the night shift hands over patients, starting with the critical ones. They describe their symptoms and what patients they suggest the day team focus on. Then we go inside. We put on personal protective equipment, following a checklist. We have a buddy system, and we have a third person who is monitoring what we are doing. Once we are in boots and scrub suits, we wash our hands and then put on the first layer of gloves. We put on coveralls. A supervisor comes and zips them for us, to insure that the zipper reaches the neck. After the coveralls, we put on a surgical mask or N95, and then we put goggles on top. When we speak, the supervisor sees if it creates any fog on the goggles, and he adjusts or replaces them before we enter. Then we put on a second pair of gloves on top of the coveralls, up to the mid-arm.

“After that, we put on a hood, and then an apron. We are checked for any leaks of air, and they write our names on a piece of tape on the apron. This way we know each other when we are inside, and the patient knows whom he is talking to. They write, also, the time when we finish putting on the full P.P.E. If I finish before my buddy, my time is written first. We monitor who reaches a maximum of one hour inside the P.P.E. so that the buddy can tell him to go out.

“Most of the time, when doctors enter, the nurses go through the vital signs, but for critical patients we have to take vitals again and do a quick A.B.C.D. (airway, breathing, circulation, disability) assessment. If there are not many critical patients, we can see up to six patients in one hour. But when there are more critical patients we sometimes see only two. We go out, refresh, and then go back after one or two hours of rest.

“Before we leave the red zone, we write the status of the patient. In Bunia, we have a Plexiglas divider where we hang what we’ve written. The clinician on the other side can quickly copy the notes before we discard them in the red zone. (In Beni, we go to a designated area within the E.T.C. where we can talk to clinicians who are on the other side—the green side. We dictate to them each patient’s instructions.) Once we finish that, we doff our P.P.E. under supervision. Someone receives us with a bottle of water and biscuits. And then we go sit down, recover for a few minutes, and we start discussing each patient again.

“The first obvious thing you feel in P.P.E. is the heat. It’s really hot. You are putting everything on top of the scrubs that you are wearing. I come out of the red zone and I’m totally wet with sweat. I’ve seen in past outbreaks, like in Liberia, colleagues falling inside P.P.E. The second thing is breathing. When you have everything on, there is a barrier for airflow. Often, if the supervisor did not pay attention, we have to say, ‘O.K., let’s go out, because your goggles are fogging.’ If you don’t see well, you can easily stumble on something and fall.

“In the red zone, I know I’m going to see patients who are confirmed to have Ebola. If I make any mistake, I will also be in quarantine for twenty-one days—or I will also be infected. So we enter with that anxiety, knowing that this is a risk that I’m taking. I know that everybody has that level of fear. But I have to go. Because I’ve been in many other outbreaks, I trust that, if I respect the protocols, there is nothing that will happen to me. And that has helped me a lot in gaining confidence. I always tell my colleagues that, if we continue to respect the protocol, none of us will be affected.

“People need to be trained well to avoid being in a panic when they are removing the P.P.E., because that’s the critical moment. We have entered the red zone. We have touched patients. Our colleagues sometimes have to mop the blood of confirmed patients, or body fluids. I myself was taking care of a patient, and he sneezed and everything went on my apron. We have a mirror so that you can see what you are doing. We have, also, a huge banner showing each step. And then there is a person in the green zone, in light P.P.E., who is also giving instructions: ‘O.K., now you can wash your hands.’ And then we have a sprayer who is spraying us with disinfectant. If there is visible soiling on our P.P.E., he cannot spray, because he will spread those things. So he will just tell us what to do, like removing it carefully and dropping it in chlorine very quickly before we wash hands.

“Recently, a man in his forties was brought in. He had spent two weeks with symptoms. He had a light fever first, with vomiting and muscle pain, but it was mild enough for him to stay in the community. And then when symptoms started to worsen—especially when he started having profuse diarrhea and vomiting, ten days later—he was brought to us. He was already very weak. He was no longer fully conscious and was not able to listen. And he was still passing a lot of diarrhea. Because of vomiting, we put in a nasogastric tube. A moment later, he started bleeding everywhere.

“That is one of the things that I don’t wish anybody to see—a human being bleeding from wherever you have an opening. Nose, eyes, mouth. When he coughs, he spits blood. Even from his ears you see traces of blood. The urine is full of blood. So it’s quite a nightmare when you see a patient in the later stage. I’m sorry, I have that image in me. It makes me feel some emotion, as well. At that stage, it was quite difficult for the team to resuscitate him. He passed away that same day.

“There is not enough blood for transfusions. With the outbreak, they stopped collecting blood in the provinces that are affected, so blood has to come from other locations. And Congo is too big, so it has to come by flight—it has to be scheduled. So when someone reaches that level, as a doctor, you sometimes don’t have anything else to do. And I can tell you seeing a patient for whom you can’t do anything is almost a torture.

“We have a team of psychosocial workers—mental-health specialists—who are part of our team. They bring relatives of patients to a dedicated visit space. There are Plexiglas screens that allow visits without physical contact. The psychosocial workers have to be careful to make sure that they sit at least one metre away from the relatives. They explain what will happen inside, including the reason for isolation. If the relative is required to stay in quarantine for twenty-one days, we give them options like phone calls to help them talk to the person inside. We always welcome visitors. When we don’t, rumors start to spread: ‘Doctors are removing organs to sell them. That’s why they bury patients themselves.’ In reality, with Ebola, we have to do a safe burial to prevent it from spreading.

“In Bunia, I can feel a mix of fear and frustration. Everyone can see buckets of water everywhere to wash their hands before they access any public space. It’s a reminder that something is happening in this city. And then seeing the funerals being organized here creates fear among the people. Frustration because no one knows when it will end. If I meet colleagues who are not working on Ebola, at a restaurant, they ask me, ‘When are we going back to our normal life?’ And I keep telling them I don’t know—maybe six months, maybe a year. And that causes more frustration.

“When I was a kid, I witnessed what was probably the worst cholera outbreak in my city of Goma, D.R.C. It left a kind of trauma, seeing suffering all around. One of the things that helps me overcome this is when we see results. When we see someone who came in very, very sick, and then is able to walk after one week or ten days or two weeks—able to recover and go out happily, reunite with their family. Those moments, they are not every day. But, when they happen, it’s so rewarding. That’s one of the things that make it worth it.

“The second thing is the team. I manage a team that is close to a thousand people. Sometimes I’ll see a logistician working until 10 or 11 P.M., just to make sure everything is done. When I see that around me, it’s an additional motivation for me. If the people I’m working with are behaving like this, I also need to maintain that courage. We are seeing interest from journalists, from donors, from colleagues. They are asking us, ‘How are you doing? How is the situation there?’ They will support the team here to stop this outbreak. That helps us not to feel alone.”